Fexofenadine Hydrochloride 45802-0847
Product NDC
45802-0847- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- January 7, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA212971
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fexofenadine Hydrochloride | 180 mg/1 |
Drug Class
Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(1)
1 BOTTLE in 1 CARTON (45802-847-78) / 100 TABLET, FILM COATED in 1 BOTTLE